Literature DB >> 20425526

Heparin and aspirin versus aspirin alone for prevention of recurrent pregnancy loss.

Robert A S Roubey1.   

Abstract

Entities:  

Year:  2010        PMID： 20425526     DOI： 10.1007/s11926-009-0076-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  8 in total

1.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Authors:  F S Cowchock; E A Reece; D Balaban; D W Branch; L Plouffe
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

2.  Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.

Authors:  R D Franklin; W H Kutteh
Journal:  Hum Reprod       Date:  2002-11       Impact factor: 6.918

3.  Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.

Authors:  W H Kutteh
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

4.  Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

Authors:  R Rai; H Cohen; M Dave; L Regan
Journal:  BMJ       Date:  1997-01-25

5.  Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.

Authors:  N S Pattison; L W Chamley; M Birdsall; A M Zanderigo; H S Liddell; J McDougall
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

6.  Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.

Authors:  Luis S Noble; William H Kutteh; Nanette Lashey; Rodney D Franklin; Juan Herrada
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

7.  Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.

Authors:  Roy G Farquharson; Siobhan Quenby; Michael Greaves
Journal:  Obstet Gynecol       Date:  2002-09       Impact factor: 7.661

8.  Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Authors:  Carl A Laskin; Karen A Spitzer; Christine A Clark; Mark R Crowther; Jeff S Ginsberg; Gillian A Hawker; John C Kingdom; Jon Barrett; Michael Gent
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666
  8 in total
  2 in total

1.  High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.

Authors:  Johanna Gebhart; Florian Posch; Silvia Koder; Peter Quehenberger; Thomas Perkmann; Lorenz Kuessel; Cihan Ay; Ingrid Pabinger
Journal:  Blood Adv       Date:  2019-03-12

Review 2.  Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.

Authors:  Malgorzata M Bala; Elżbieta Paszek; Wiktoria Lesniak; Dorota Wloch-Kopec; Katarzyna Jasinska; Anetta Undas
Journal:  Cochrane Database Syst Rev       Date:  2018-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.